These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4861322)

  • 1. Evaluation of CI-564, A 1:1 mixture of cycloguanil pamoate (CI-501) and 4,4'-diacetylaminodiphenylsulfone (CI-556), against multiresistant falciparum malarias.
    Chin W; Contacos PG; Coatney GR; Jeter MH; Alpert E
    Am J Trop Med Hyg; 1967 Sep; 16(5):580-4. PubMed ID: 4861322
    [No Abstract]   [Full Text] [Related]  

  • 2. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1966 May; 15(3):281-6. PubMed ID: 5328125
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to cycloguanil pamoate (CI-501) by falciparum malaria in West Pakistan.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1965 Nov; 14(6):925-6. PubMed ID: 5320456
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility of Plasmodium falciparum to the drugs used to treat severe malaria (quinine) and to prevent malaria (mefloquine, cycloguanil) in Comoros Union and Madagascar.
    Randrianarivelojosia M; Randrianasolo L; Randremanana RV; Randriamanantena A; Ratsimbasoa A; Rakotoson JD
    S Afr Med J; 2004 Jan; 94(1):47-51. PubMed ID: 14971233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France.
    Durand R; Ramiliarisoa O; Sécardin Y; Eldin de Pécoulas P; Basco LK; Le Bras J
    Trans R Soc Trop Med Hyg; 1997; 91(4):460-1. PubMed ID: 9373655
    [No Abstract]   [Full Text] [Related]  

  • 6. A field trial of the effectiveness of cycloguanil pamoate in Rhodesia.
    Harwin RM
    Cent Afr J Med; 1973 Jan; 19(1):9-12. PubMed ID: 4576484
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in drug response of the sporogonous cycles of three strains of Plasmodium falciparum in Anopheles stephensi.
    Terzian LA; Stahler N; Dawkins AT
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):16-24. PubMed ID: 4400231
    [No Abstract]   [Full Text] [Related]  

  • 8. The repository antimalarial activities of 4,4'-diacetylaminodiphenylsulfone and cycloguanil pamoate (Cl-501) in monkeys relative to local release following parenteral administration.
    Thompson PE; Waitz JA; Olszewski B
    J Parasitol; 1965 Jun; 51(3):345-9. PubMed ID: 4953989
    [No Abstract]   [Full Text] [Related]  

  • 9. Malaria. Chemoprophylaxis and chemotherapy.
    Peters W
    Br Med J; 1971 Apr; 2(5753):95-8. PubMed ID: 4927912
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical testing of new antimalarial compounds.
    Canfield CJ; Rozman RS
    Bull World Health Organ; 1974; 50(3-4):203-12. PubMed ID: 4613503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of new antimalarial drugs.
    Powell RD
    Am J Trop Med Hyg; 1972 Sep; 21(5):744-8. PubMed ID: 4561522
    [No Abstract]   [Full Text] [Related]  

  • 12. The antimalarial activity of N-benzyloxydihydrotriazines. II. The development of resistance to clociguanil (BRL 50216) and cycloguanil by P. berghei.
    Knight DJ; Williamson P
    Ann Trop Med Parasitol; 1980 Aug; 74(4):405-13. PubMed ID: 6450572
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of CI-564 against blood-induced chlorguanide-sensitive and chlorguanide-resistant strains of vivax malaria.
    Chin W; Coatney GR; King HK
    Am J Trop Med Hyg; 1967 Jan; 16(1):13-4. PubMed ID: 5336629
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistance of Plasmodium falciparum to synthetic antimalarials].
    da Silva JR; Lopes PF
    Hospital (Rio J); 1966 May; 69(5):967-79. PubMed ID: 5328966
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). III. Methods employed in the search for new blood schizonticidal drugs.
    Schmidt LH
    Am J Trop Med Hyg; 1978 Jul; 27(4):718-37. PubMed ID: 99057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The problem of drug-resistant malaria.
    Clyde DF
    Am J Trop Med Hyg; 1972 Sep; 21(5):736-43. PubMed ID: 4561521
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of malaria.
    Rozman RS
    Annu Rev Pharmacol; 1973; 13():127-52. PubMed ID: 4576886
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance to chloroquine and cycloguanil of Plasmodium falciparum in patients arriving in France after travel in Africa without chemoprophylaxis].
    Le Bras J; Pradines B; di Piazza JP; Durand R; Godineau N; Bouchaud O; Roué R; Marchou B; Martet G; Longuet C; Parzy D
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):490-2. PubMed ID: 10078392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of the drug-resistant malarias.
    Schmidt LH
    Annu Rev Microbiol; 1969; 23():427-54. PubMed ID: 4901983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.